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Cross-screening in observational studies that test many hypotheses
Qingyuan Zhao, Dylan S. Small, Paul R. Rosenbaum1
University of Pennsylvania, Philadelphia
Abstract. We discuss observational studies that test many causal hypotheses, either hypotheses
about many outcomes or many treatments. To be credible an observational study that tests
many causal hypotheses must demonstrate that its conclusions are neither artifacts of multiple
testing nor of small biases from nonrandom treatment assignment. In a sense that needs to be
defined carefully, hidden within a sensitivity analysis for nonrandom assignment is an enormous
correction for multiple testing: in the absence of bias, it is extremely improbable that multiple
testing alone would create an association insensitive to moderate biases. We propose a new
strategy called “cross-screening,” different from but motivated by recent work of Bogomolov
and Heller on replicability. Cross-screening splits the data in half at random, uses the first half
to plan a study carried out on the second half, then uses the second half to plan a study carried
out on the first half, and reports the more favorable conclusions of the two studies correcting
using the Bonferroni inequality for having done two studies. If the two studies happen to
concur, then they achieve Bogomolov-Heller replicability; however, importantly, replicability is
not required for strong control of the family-wise error rate, and either study alone suffices
for firm conclusions. In randomized studies with a few hypotheses, cross-split screening is not
an attractive method when compared with conventional methods of multiplicity control, but it
can become attractive when hundreds or thousands of hypotheses are subjected to sensitivity
analyses in an observational study. We illustrate the technique by comparing 46 biomarkers in
individuals who consume large quantities of fish versus little or no fish.
Keywords: Bonferroni inequality; causal inference; design sensitivity; observational study;
replicability; sample splitting; sensitivity analysis.
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1 Introduction: testing many hypotheses in observational studies
1.1 Sensitivity analyses and corrections for multiple testing affect one another
To be credible, an observational or nonrandomized study that tests many null hypotheses
about treatment effects must demonstrate that claimed effects are neither an artifact of
testing many hypotheses nor a consequence of small departures from randomized treatment
assignment. These two demonstrations are related. Tiny treatment effects have almost no
chance of being judged insensitive to small unmeasured biases from nonrandom assignment;
see Rosenbaum (2015, §5). With many null hypotheses, tiny treatment effects also have
almost no chance of being distinguished from artifacts of multiple testing in studies of
moderate sample size. These two considerations motivate screening to eliminate null
or negligible treatment effects before testing, thereby greatly reducing the correction for
multiple testing.
To see that tiny effects have almost no chance of being distinguished from artifacts
of multiple testing in studies of moderate sample size, suppose there are I independent
observations on each ofK independent outcomes, where outcome k isN (τk, 1), with the kth
null hypothesis asserting Hk : τk = 0, where in fact τ1 = τ > 0 and τ2 = τ3 = · · · = τK = 0.
In this case, the probability that the only active group, k = 1, has a sample mean above the
K − 1 other group means is ̟τ,K,I =
∫
∞
−∞
Φ
(
y/
√
I
)K−1
φ
{
(y − τ) /√I
}
/
√
I dy, where
Φ (·) and φ (·) are, respectively, the standard Normal cumulative and density functions.
With I = 100 observations and K = 100 hypotheses, ̟τ,K,I is 0.082 for τ = 0.1, 0.501
for τ = 0.25 and 0.988 for τ = 0.5. So, we are unlikely to locate the one real effect if
τ = 0.1 and very likely to locate it if τ = 0.5. As I →∞ with τ and K fixed, ̟τ,K,I → 1;
however, this limiting calculation is less relevant in the problems we often face in which K
is fairly large and I is not enormous relative to K. An effect of τ = 0.5 with I = 100 is also
likely to be judged insensitive to substantial biases from nonrandom treatment assignment;
see Rosenbaum (2010, §14.2, p. 268). As will be seen in later sections, we can reduce
the magnitude of a correction for multiple testing by screening out negligible effects that
never had a chance of surviving a sensitivity analysis, and had little chance of surviving a
correction for multiple testing.
In the current paper, we propose a new technique called cross-screening. The sample
is split in half at random. The first half is used to plan the analysis of the second half,
for instance, selecting null hypotheses that appear to be false, the one-tailed direction of
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the likely departure from the null, and the best test statistic to use in testing. In parallel,
the second half is used to plan the analysis of the first half. Both halves are analyzed
using these data-derived plans, and the more favorable results of the two analyses are
reported with a Bonferroni correction for performing two analyses. Both halves are used
to plan and both halves are used to test, so cross-screening uses all of the data to test
hypotheses. Cross-screening strongly controls the family-wise error rate, as discussed in
§2.1. We compare cross-screening to alternative methods, such as a Bonferroni correction
for testing K two-sided hypotheses, or screening using a small fraction of the data. Cross-
screening performs poorly except when K is large and I is not extremely large, but it often
wins decisively in sensitivity analyses with large K and moderate I/K. Cross-screening
is related to, though distinct from, a concept of replicability developed by Bogomolov and
Heller (2013); see §2.4 and §6 for detailed discussion. Cross-screening rejects hypothesisHk
if either half-sample rejects Hk, thereby strongly controlling the family-wise rate; however,
it achieves Bogomolov-Heller replicability if both halves reject Hk.
1.2 Outline: a general method; measures of performance
As it turns out, our simplest results are also our most definite and most useful results, so
we present them first §2, after fixing ideas with a motivating example in §1.3. Section 4
presents a series of incomplete evaluations of cross-screening; however, the simulation in §5
can be read immediately after §2. Alas, the attraction of cross-screening is its flexibility,
but it is this very flexibility that makes it difficult to offer a definitive evaluation. Suffice
it to say here that cross-screening performs well in certain situations and from certain
vantage points, but it performs poorly in others, and a user of the method needs to be
aware of both aspects. The formal evaluation in §4 requires some notation and definitions
that are reviewed in §3, whereas some of these same ideas appear informally in §2. Finally,
§6 considers nonrandom cross-screening.
1.3 Example: eating fish and biomarkers
Using the National Health and Nutrition Examination Survey (NHANES) 2013-2014, we
defined high fish consumption as more than 12 servings of fish or shellfish in the previous
month, and low fish consumption as 0 or 1 servings of fish. We matched 234 adults with
high fish consumption to 234 adults with low fish consumption, matching for gender, age,
income, race, education and smoking. Income was measured as the ratio of income to the
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poverty level capped at five times poverty. Smoking was measured by two variables: (i)
having smoked a total of at least 100 cigarettes, and (ii) cigarettes currently smoked per
month. Figure 1 shows the distribution of age, income, education and smoking for the
matched high and low groups. For brevity, we refer to high fish consumption as treated,
and to low fish consumption as control.
We compared the treated and control groups in terms of the logs of K = 46 biomarkers.
All biomarkers were nonnegative, and when a biomarker could equal zero, we added one to
that biomarker so that logs could be taken. Base 2 logs are used, so that a treated-minus-
control difference of 1 implies the treated person’s response is twice the matched control’s
response. Generally, if the difference is y > 0 then the control’s response must be doubled
y times to yield the matched treated subject’s response, and if the the difference is y < 0
then the treated subject’s response must be doubled y times to yield the matched control’s
response. Figure 2 shows the 234 treated-minus-control matched pair differences, i = 1, 2,
. . . , I = 234, in the logs of the K = 46 biomarkers, k = 1, . . . ,K = 46. A few biomarkers
show large differences.
Table 1 compares two multiplicity-corrected sensitivity analyses for the data depicted
in Figure 2. Method B applies a Bonferroni correction to Wilcoxon’s signed rank test
using the sensitivity analysis that is discussed in Rosenbaum (1987; 2002, §4; 2011) and
that is reviewed briefly in §3.2. Specifically, method B performs 2×46 one-sided sensitivity
analyses, one in each tail for K = 46 outcomes, and obtains an upper bound on each one-
sided P -value in the presence of a bias of at most Γ. Here, Γ ≥ 1 measures the magnitude
of the departure from random assignment within pairs, such that two matched people
might differ in their odds of treatment by a factor of Γ due to some unmatched covariate;
see §3.2. The B method takes as the adjusted P -value for a biomarker the smaller of 1
and 2×K = 2× 46 times the smaller of the two P -value bounds for that biomarker. For
Γ = 1, this is simply the Bonferroni correction applied to K = 46 two-sided Wilcoxon tests,
and for (Γ = 1, K = 1) it is simply a two-sided Wilcoxon test. For biomarkers k = 15,
18, 21, and 23, the corrected P -values are below 0.05 in a randomization test with Γ = 1.
Biomarker k = 15 is sensitive to a nontrivial bias of Γ = 1.25, but biomarkers k = 18, 21,
and 23 are not. Biomarker k = 21 becomes sensitive at Γ = 1.76 with a corrected P -value
bound of 0.054. Biomarkers k = 18 and 23 are sensitive to a bias of Γ = 9 with P -value
bounds of 0.095 and 0.075, respectively, but they are insensitive to a bias of Γ = 8 with
P -value bounds of 0.030 and 0.023 (not shown in Table 1). Perhaps unsurprisingly, the
noticeable differences between high and low consumers of fish are high levels of mercury in
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the blood of high consumers.
When used in sensitivity analyses, the two-sided Bonferroni method is somewhat con-
servative. A brief explanation of this follows, but the remainder of this paragraph is not
essential to the paper and may be skipped. It is correct but conservative to say: If the
bias in treatment assignment is at most Γ, and if K hypotheses are tested, then the prob-
ability is at most α that at least one true null hypothesis yields a one-sided P -value bound
less than or equal to α/ (2K); see Rosenbaum and Silber (2009a, §4.5). The Bonferroni
method is conservative for three reasons. First, of course, the Bonferroni inequality is
an inequality, not an equality. Second, the one-sided P -value bound is obtained by max-
imizing the probability in one tail, thereby depleting the opposite tail, so doubling the
one-sided P -value bound is conservative for a two-sided test when Γ > 1. Third, when
Γ > 1, the worst pattern of biases for one outcome is often not the worst pattern for other
outcomes, and the Bonferroni method ignores this. The Bonferroni-Holm method is least
conservative when different outcomes have effects of very different magnitudes, and it is
most conservative when many weakly correlated outcomes have effects of nearly the same
size. Fogarty and Small (2016) propose an optimization technique that eliminates this
third source of conservatism. An additional consideration, not strictly a form of conser-
vatism, is that it may not be best to think about K = 46 individual outcomes; rather,
there may be greatest insensitivity to bias for some linear combination of the K outcomes;
see Rosenbaum (2016).
The second method in Table 1 is cross-screening (CS), and it is defined in §2. Notably
in Table 1, cross-screening judges outcomes k = 18 and 23 to be insensitive to a bias of
Γ = 9 while method B judges them sensitive to Γ = 9; indeed, method CS judges these two
outcomes insensitive to a bias of Γ = 11. As discussed later, we expect cross-screening to
lose to method B in a randomization test, Γ = 1, or when I/K is large. We offer reasons
to expect cross-screening to perform well, as it does in Table 1, when allowance is made
for a nontrivial bias, Γ ≥ 1.25, and I/K is not large.
2 What is random cross-screening?
2.1 Definition and control of the family-wise error rate
Random cross-screening begins by splitting the data set in half at random, yielding two
groups of I/2 pairs, or 234/2 = 117 pairs in Figure 2. The unusual aspect of cross-screening
is that both halves are used to screen and both halves are used to test. Indeed, each half
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suggests a way to test in the other half, suggesting a one-tailed test in a particular direction,
and guiding the choice of test statistic. The method strongly controls the family-wise error
rate, so that the probability that it falsely rejects at least one true null hypothesis is at
most α providing the bias in treatment assignment is at most Γ.
Cross-screening may provide a still stronger conclusion in which the two halves replicate
each other, in the sense described by Bogomolov and Heller (2013). Indeed, cross-screening
is a modification, at a crucial step, of their replicability method, but refers to random halves
of a single study rather than to two independent studies by different investigators. We
first define random cross-screening in §2.1, discuss aspects of implementation in §2.2, and
illustrate it in the example in §2.3, then discuss its connection to replicability in §2.4.
Although intuitively pleasing, the technical value of replication with random halves is not
obvious; however, in §6, we discuss nonrandom cross-screening, and in this case a single
investigator may attach importance to replication of two parts of one investigation.
There are K null hypotheses, Hk, k = 1, . . . ,K. In Figure 2, there are K = 46 null
hypotheses, the kth hypothesis asserting no effect of treatment on the kth biomarker. Fix
α with 0 < α < 1; conventionally, α = 0.05. If S is a finite set, write |S| for the number
of elements in S.
A mild premise of our discussion of sample splitting is that the I units in the sample
are independent of each other, and that the K hypotheses refer to either a finite or infinite
population containing these I units. At the risk of belaboring this premise, it is useful to
mention a few particulars to avoid any possibility of misunderstanding. In §1.3, there are
I = 234 matched pairs, distinct pairs are assumed independent, and the hypotheses refer
either to the I = 234 pairs as a finite population or to a finite or infinite population from
which they were drawn. If the I units are clustered, so that units in distinct clusters are
independent, then the clusters, not the I units, should be split at random into two groups
of clusters, keeping individual clusters intact in one group or the other. Cross-screening is
not applicable if the I units are from a single time series of length I. Also, the hypotheses
are about the population, whether finite or infinite, in the sense that each Hk is either true
or false as a description of the population. For example, if H3 asserted that at least one
person in the finite population of I = 234 pairs of people is over 100 years old, then H3 is
true if at least one person in the I = 234 pairs of people is over 100 years old; otherwise, it
is false. When we split the sample in half at random, H3 continues to refer to the I = 234
pairs of people; that is, it does not become two new hypotheses, H
′
3
and H
′′
3
, about two
randomly defined groups of 234/2 = 117 pairs of people, where H
′
3
might be true and H
′′
3
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might be false, depending upon how the random split came out.
Random cross-screening is defined by the following four steps. Essentially, each random
half of the data is extensively used to plan the analysis of the other half, and then the two
separate analyses are combined by correcting for doing two analyses.
Step 1: Split the sample in half at random.
Step 2: Use the first half in any way at all to select hypotheses H2 ⊆ {1, . . . ,K} to test
using the second half, with 1 ≤ K2 = |H2| ≤ K. At the same time, use the first
half in any way at all to select a test statistic T2k to use in the second half in testing
Hk for k ∈ H2. In the second half, use some method for testing the hypotheses
in H2 that would strongly control the family-wise error rate at α/2 if only the K2
hypotheses in H2 were tested using T2k for k ∈ H2. Let R2 ⊆ H2 be the set of
rejected hypotheses.
Step 3: Use the second half in any way at all to select hypotheses H1 ⊆ {1, . . . ,K}
to test using the first half, with 1 ≤ K1 = |H1| ≤ K. At the same time, use the
second half in any way at all to select a test statistic T1k to use in the second half in
testing Hk for k ∈ H1. In the first half, use some method for testing the hypotheses
in H1 that would strongly control the family-wise error rate at α/2 if only the K1
hypotheses in H1 were tested using T1k for k ∈ H1. Let R1 ⊆ H1 be the set of
rejected hypotheses.
Step 4: Reject Hk if k ∈ R = R1 ∪R2.
It is not novel to split a sample at random into two independent subsamples, plan the
study using the first subsample, carry out the plan with the independent second subsample,
viewing decisions from the first subsample as fixed; see, for instance, Cox (1975) or Heller
et al. (2009). That is, Step 2 is not novel on its own, nor is Step 3 on its own. The novel
element in cross-screening is that this process is done twice, with each subsample playing
both roles, and if either version rejects Hk then Step 4 rejects Hk. In a limited sense,
cross-screening uses all of the data to plan and all of the data to test.
The basic property of cross-screening is that it strongly controls the family-wise error
rate, as discussed in the following proposition. Strong control of the family-wise error rate
means that the probability of falsely rejecting at least one true null hypothesis is at most
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α no matter which of the K hypotheses are true. Let T ⊆ {1, . . . ,K} be the unknown,
possibly empty, set of indices such that Hk is true if and only if k ∈ T .
Proposition 1 At least one true null hypothesis, Hk with k ∈ T , is falsely rejected by
cross-screening, with k ∈ R, with probability Pr (T ∩ R 6= ∅) ≤ α.
Proof. WriteA1 for all of the observed data in the first half sample, andA2 for all of the ob-
served data in the second half sample. From Step 2 of cross-screening, Pr (T ∩ R2 6= ∅ | A1) ≤
α/2, so that Pr (T ∩ R2 6= ∅) = E {Pr (T ∩ R2 6= ∅ | A1)} ≤ α/2. In parallel, from Step
3, Pr (T ∩ R1 6= ∅) ≤ α/2. By the Bonferroni inequality,
Pr (T ∩R 6= ∅) = Pr {(T ∩ R1 6= ∅) or (T ∩ R2 6= ∅)}
≤ Pr (T ∩R1 6= ∅) + Pr (T ∩ R2 6= ∅) ≤ α
2
+
α
2
= α. (1)
Could use of the Bonferroni inequality in (1) be replaced by an appeal to the in-
dependence of the two half-samples, so that Pr (T ∩ R 6= ∅) = 1 − (1− α)2 instead of
Pr (T ∩ R 6= ∅) ≤ α? It cannot. Although the two half samples are independent of each
other, the event (T ∩ R1 6= ∅) depends upon both halves, as does the event (T ∩ R2 6= ∅),
as seen in Steps 2 and 3 of the description of cross-screening. The choices about which
hypotheses to test in the second sample, H2, and the choice of test statistics, T2k, to use
when testing hypotheses in H2, were based on the first sample. However, conditionally
given those choices, the chance of at least one false rejection in R2 is at most α/2, because
the two halves are independent. The situation is parallel for R1.
2.2 Aspects of implementing cross-screening
In Step 2 of cross-screening, we would typically uses the first half sample to select a small
number K2 = |H2| of hypotheses, perhaps even K2 = 1, that appear most likely to be
rejected when tested in the second half sample. Also, we would pick test statistics, T2k for
k ∈ H2, that are mostly likely to reject those hypotheses. A simple way to do this is to test
every hypothesis k ∈ {1, . . . ,K} using several test statistics in the first half sample, and
then pick for use in the second sample the hypotheses and test statistics with the smallest
P -values in the first sample. Analogous considerations apply to Step 3 of cross-screening.
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In particular, cross-screening permits a few one-sided tests to be performed, rather than
many two-sided tests. Shaffer (1974) and Cox (1977, §4.2) discuss reasons for viewing a
two-sided test of Hk as two one-sided tests of Hk with a Bonferroni correction for testing
Hk twice, say by rejecting Hk if either T2k or −T2k is large. In cross-screening, we might
decide in Step 2 to use either T2k or −T2k, not both, as our test statistic in the second
half based on what we observed in the first half, thereby omitting the 2-fold Bonferroni
correction needed for a two-sided test. In §1.3, if the first half sample suggested that eating
lots of fish increased a particular biomarker with a long-tailed distribution, we might select
that biomarker for testing in the second sample, using a one-sided robust test, looking only
for an increase in that biomarker in the second sample.
Suppose that we always picked a single hypothesis to test, so that 1 = K1 = |H1| =
K2 = |H2|. Then the two halves might select two different hypotheses, H1 6= H2, and
either or both hypotheses might be rejected in Step 4 of cross-screening.
A reasonable strategy is to insist that K1 and K2 each be at least 1 but much less
than K. There is little or no hope of outperforming the Bonferroni correction for K
hypotheses if K1 and K2 are near K. Even if no hypothesis looks especially promising
based on the first half sample, the power of the overall procedure can only be hurt by
taking 0 = K2 = |H2|. In Table 1, we set K1 = K2 = 2, selecting the two least sensitive
hypotheses in one half-sample for testing in the other half-sample, using the Bonferroni
inequality in Steps 2 and 3 to strongly control the family-wise error rate when testing
K1 = K2 = 2 hypotheses. As it turned out, both half samples selected hypotheses H18
and H23 for testing in the complementary half; that is, H1 = H2 = {18, 23}. One could
instead use Holm’s (1979) method for two hypotheses in Steps 2 and 3, thereby gaining in
power.
A better approach does not select hypotheses, but rather orders them, and tests them
in sequence by a method that controls the family-wise error rate. We recommend ordering
hypotheses so that the least sensitive hypothesis appears first. In the planning half, one
performs a sensitivity analysis for each outcome, determines the Γ at which this outcome
becomes sensitive to bias, and orders hypotheses in decreasing order of sensitivity to bias.
This approach avoids an arbitrary decision about how many hypotheses to test, but it
emphasizes the most promising hypotheses. For methods that control the family-wise
error rate at α when testing hypotheses in a given order, see, for instance: Gansky and
Koch (1996), Hsu and Berger (1999), Wiens (2003), Hommel and Kropf (2005), Rosenbaum
(2008) and Burman, Sonesson and Guilbaud (2009). The simplest approach — so-called
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fixed sequence testing — tests the first hypothesis at level α, stops testing if this hypothesis
is accepted, otherwise tests the second hypothesis at level α, continuing until the first
acceptance; see, for instance, Gansky and Koch (1996). Wiens (2003) and Hommel and
Kropf (2005) test at a level below α, perhaps at α/2, so they can continue beyond the first
acceptance; moreover, they transfer unspent α forward to later hypotheses. Wiens calls
this a fall-back procedure. Burman et al. (2009) extend that strategy, recycling some
unspent α backwards to previously accepted hypotheses. Our simulation in §5 evaluates
these methods.
The hypotheses H2 and test statistics T2k picked in Step 2 must be a function of the
first half sample, without input from the second half sample. Otherwise, treating H2 and
T2k as fixed when testing in the second sample would not be the same as conditioning on
their observed values, a key part of Proposition 1. In parallel, the hypotheses H1 and test
statistics T1k picked in Step 3 must be a function of the second half sample, without input
from the first half sample. The most natural, the most convenient, and the most public
way to do this is with an explicit function or algorithm that makes these choices, and we
recommend that approach in practice. Notice, however, that if, without communicating,
one coauthor informally used the first half sample to pick H2 and test statistics T2k, while
a second coauthor informally used the second half sample to pick H1 and test statistics
T1k, then Proposition 1 would continue to hold.
2.3 Cross-screening in the example
Consider blood mercury (LBXTHG or k = 18) in Table 1. In a conventional randomization
test, Γ = 1, all of the P -values for H18 are extremely small and both B and CS reject the
hypothesis of no effect. At Γ = 9, the one-sided Wilcoxon test using all of the data has
P -value bound 0.001036 and multiplying this by 2× 46 yields 0.095, so method B does not
reject in row 18 of in Table 1.
The illustration of cross-screening in Table 1 selects the K1 = K2 = 2 least sensitive
hypotheses in each half-sample for testing in the complementary half sample. As it turns
out, both half-samples selected hypotheses H18 and H23 for testing, both referring to
mercury levels in the blood. Later, in the simulation in §5, we consider methods that do
not fix the number of hypotheses to be tested.
In cross-screening, one-sided tests are performed, with the direction of the alternative
being determined by the complementary half sample. Additionally, two test statistics were
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tried in one-half sample, and one was selected for testing in the complementary half. One
test was Wilcoxon’s signed rank test; the other was a U-statistic called (8,5,8) proposed
in Rosenbaum (2011) and discussed further in §3. For hypothesis H18, one-sided P -value
bounds from Wilcoxon’s statistic at Γ = 9 are, respectively, 0.03445 and 0.00647 in the first
and second half samples. The one-sided P -value bounds from the U-statistic (8,5,8) are,
respectively, 0.02132 and 0.00383 in the first and second half samples. The quoted P -value
bound for k = 18, Γ = 9 in Table 1 is four times the smallest of these, 0.015 = 4× 0.00383.
This is because, in Step 2, the first sample suggested testing H18 and H23 in the second
sample. Moreover, in Step 2, the first sample suggested using the U-statistic in the second
sample because 0.03445 > 0.02132. In the second sample, these two hypotheses were
tested, and Step 2 requires that the family-wise error in these two tests be controlled at
α/2, so each test was performed at level α/4 = (α/2) /2. The smallest level α that leads
to rejection is 0.015 = 4 × 0.00383, yielding the quoted P -value from R2. It is beside
the point, but nonetheless interesting that the second half sample would also have selected
hypotheses H18 and H23, and would have recommended testing H18 with the U-statistic,
and it would have yielded a P -value bound of 0.0259 = 4×0.00647 from R1. So, at Γ = 9,
the two halves concur in rejecting H18 at the 0.05 level, but we only needed rejection
in either half in Step 4. In contrast, at Γ = 11, both half samples recommend testing
H18 and H23 using the U-statistic; however the P -value bounds for H18 are 0.04589 and
0.00865 in the two halves, so that only the second half sample, R2, leads to rejection with
0.05 > 0.035 = 4× 0.00865.
This P -value bound of 0.035 from CS should be compared with the P -value bound of
0.505 from the Bonferroni method at Γ = 11. The Bonferroni method corrects for K = 46
two-sided tests, while cross-screening corrects for 4 one-sided tests, two in each of two half
samples. Additionally, cross-screening adaptively selected for use in one half sample the
test statistic that performed best in the other half sample.
2.4 Cross-screening and replicability
With a different goal in view, Bogomolov and Heller (2013) used a procedure similar in
form to Steps 1 to 3 of cross-screening, but with a different Step 4, and with some other
differences. They asked whether two independent studies by different investigators testing
the same K hypotheses have replicated each other. Their method says that rejection of
Hk has replicated if k ∈ R1 ∩R2, whereas Step 4 rejects Hk in one study if k ∈ R1 ∪R2;
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that is, both studies must reject Hk to replicate, rather than either half rejecting Hk to
control the family-wise error rate in a single study. Obviously, (R1 ∩R2) ⊆ (R1 ∪R2) so
the probability of replication is lower than the probability of rejection in cross-screening.
In the numerical example in §2.3, hypothesis k = 18 ∈ R1 ∩R2 for Γ = 9, thereby meeting
Bogomolov and Heller (2013)’s standard for replication; at Γ = 11, however, 18 /∈ R1 ∩R2
but 18 ∈ R1 ∪R2, so H18 is rejected by cross-screening without meeting the standard for
replication.
As Bogomolov and Heller (2013) emphasize, when asking about replicability of two
independent studies, it is possible that Hk is genuinely true in one study and genuinely
false in the other: there might be a treatment effect for outcome k in Cleveland and not
in Kyoto, or a specific gene variant might have an effect in a study done on one ethnic
group, but not in a study done on a different ethnic group. In contrast, with a random
split of a random sample from a single population, Hk is either true in the population or
false in the population. Additionally, Steps 2 and 3 of cross-screening treat the two half
samples symmetrically, each informing the analysis of the other, for instance the choice
of test statistic, or the choice of tail for a two-sided test. With two independent studies
by different investigators, it is likely that one study came first, so symmetry is unlikely.
Perhaps the earlier study influenced the design and analysis of the later study, but the
symmetry of Steps 2 and 3 is not expected when one study follows another.
Section 6 discusses an intermediate case involving nonrandom cross-screening in a single
study. With nonrandom cross-screening in §6, it is interesting to know both whether
k ∈ R1 ∩R2 and also whether k ∈ R1 ∪R2.
3 Notation for paired randomized experiments and observational studies
3.1 Causal inference in paired randomized experiments
Cross-screening, as described in §2, is quite general. It could be used with matched pairs,
matched sets with multiple controls, full matching, unmatched comparisons, with cohort
or case-control studies. The simplest case, however, concerns treatment-control matched
pairs, as in §1.3, and the evaluation in §4 will be restricted to this simplest case.
There are I matched pairs, i = 1, . . . , I, of two individuals, j = 1, 2, one treated with
Zij = 1, the other an untreated control with Zij = 0, so 1 = Zi1+Zi2 for each i. Individuals
were matched for an observed covariate xij , so that xi1 = xi2 for each i, but there is concern
about an unmeasured covariate uij for which it is possible that ui1 6= ui2 for many or all
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pairs i. Write Z = (Z11, . . . , ZI2)
T for the 2I dimensional vector of treatment assignments,
and let Z be the set containing the 2I possible values z of Z, so z ∈ Z if z = (z11, . . . , zI2)T
with zij = 1 or 0 and zi1 + zi2 = 1 for all i, j. Conditioning on the event Z ∈ Z is
abbreviated as conditioning on Z.
There are K responses, k = 1, . . . ,K. The jth individual in pair i has two potential
outcomes for the kth response, namely rT ijk if this individual is treated with Zij = 1 or rCijk
if this individual is given control with Zij = 0, so the kth response observed from this indi-
vidual is Rijk = Zij rT ijk + (1− Zij) rCijk and the effect caused by the treatment, namely
δijk = rT ijk − rCijk, is not observed for any individual; see Neyman (1923) and Rubin
(1974). Fisher’s (1935) sharp null hypothesis of no treatment effect for response k asserts
Hk : δijk = 0 for all i and j. Write Rk = (R11k, . . . , RI2k)
T and rCk = (rC11k, . . . , rCI2k)
T ,
so that Rk = rCk when Hk is true. For the potential outcomes and covariates for the 2I
individuals, write F = [{(rT ijk, rCijk, k = 1, . . . ,K) , xij, uij} , i = 1, . . . , I, j = 1, 2].
In a paired, randomized experiment, a fair coin is flipped independently I times to assign
treatments within the I pairs, so that Pr (Z = z | F , Z) = 2−I = |Z|−1 for each z ∈ Z. A
randomization test of Hk compares the distribution of a test statistic, Tk = tk (Z,Rk), to
its randomization distribution, Pr (Tk ≥ t | F , Z), when Hk is true, namely
Pr { tk (Z,Rk) ≥ t | F , Z} = Pr { tk (Z, rCk) ≥ t | F , Z} = |{z ∈ Z : tk (z, rCk) ≥ t}||Z| ,
(2)
becauseRk = rCk whenHk is true, rCk is fixed by conditioning on F , and Pr (Z = z | F , Z) =
|Z|−1 in a randomized experiment.
A common form of test statistic Tk = tk (Z,Rk) uses the treated-minus-control matched-
pair difference, Yik = (Zi1 − Zi2) (Ri1k −Ri2k), which equals ± (rCi1k − rCi2k) when Hk is
true. The absolute pair differences, |Yik|, are assigned nonnegative scores qik ≥ 0 with
qik = 0 when |Yik| = 0. Write sgn (y) = 1 if y > 0 and sgn (y) = 0 otherwise. The random-
ization distribution of statistics of the form Tk =
∑I
i=1 sgn (Yik) qik yield many familiar
randomization tests, including: (i) Wilcoxon’s signed rank test with qik to be the rank of
|Yik|, (ii) the permutational t-test with qik = |Yik| /I, (iii) Maritz (1979)’s randomization
distribution for Huber’sM -statistic with qik = ψ (|Yik| /κ) where κ is the median |Yik| and
ψ (·) is a monotone increasing odd function, ψ (y) = −ψ (−y). Under Hk, the difference
Ri1k −Ri2k = rCi1k − rCi2k is fixed by conditioning on F , so the null distribution (2) of Tk
is the distribution of the sum of I independent random variables taking the values qik or 0
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with equal probabilities 1/2 if |Yik| > 0 or the value 0 with probability 1 if |Yik| = 0.
The U-statistic (m,m,m) = (8, 5, 8) was used in cross-screening in Table 1. Let aik be
the rank of |Yik|. In general, the U-statistic (m,m,m) has qik =
(
I
m
)−1∑m
ℓ=m
(
aik−1
ℓ−1
)(
I−aik
m−ℓ
)
;
see Rosenbaum (2011). Here, (m,m,m) = (1, 1, 1) yields the sign test, (2, 2, 2) is nearly
the same as Wilcoxon’s test, (m,m,m) = (m,m,m) for integer m ≥ 3 yields Stephenson’s
(1981) test, and (8, 5, 8) is an S-shaped transformation of the ranks that diminishes the
influence of Yik that are close to zero.
3.2 Sensitivity analysis in observational studies
A simple model for biased treatment assignment in observational studies asserts that in
the population, prior to matching, treatment assignments are independent with probabil-
ities πij = Pr (Zij = 1 | F), and two subjects, say ij and i′j′, with the same value of x,
xij = xi′j′ , may differ in their odds of treatment by at most a factor of Γ ≥ 1, that is
Γ−1 ≤ πij
(
1− πi′j′
)
/
{
πi′j′ (1− πij)
} ≤ Γ, and then conditions on Z ∈ Z. Setting γ =
log (Γ) ≥ 0, this is equivalent to introducing an unobserved covariate u = (u11, . . . , uI2)T
with 0 ≤ uij ≤ 1 such that Pr (Z = z | F , Z) = exp
(
γuT z
)
/
∑
b∈Z
exp
(
γuTb
)
for z ∈ Z,
or equivalently
Pr (Z = z | F , Z) =
∏I
i=1
θzi1i (1− θi)zi2 with
1
1 + Γ
≤ θi ≤ Γ
1 + Γ
for each i; (3)
see Rosenbaum (2002, §4) where equivalences are demonstrated by deriving uij from πij and
conversely. Define TΓk to be the sum of I independent random variables taking the value
qik ≥ 0 with probability κ = Γ/ (1 + Γ) or the value 0 with probability 1/ (1 + Γ), and define
TΓk analogously but with the probabilities reversed. Then for Tk =
∑I
i=1 sgn (Yik) qik,
it is not difficult to show under Hk and (3) that the null distribution of Tk is bounded by
two known distributions,
Pr
(
TΓk ≥ t
∣∣ F , Z) ≤ Pr (Tk ≥ t | F , Z) ≤ Pr(TΓk ≥ t ∣∣∣ F , Z) , (4)
from which bounds on P -values, point estimates and confidence intervals are obtained. In
particular, the upper bound on the one-sided P -value is obtained by evaluating Pr
(
TΓk ≥ t
∣∣∣ F , Z)
in (4) with t set to the observed value of the test statistic, Tk. Under mild conditions on
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the scores, qik, as I →∞, the upper bound in (4) can be approximated by
Pr
(
TΓk ≥ t
∣∣∣ F , Z) .= 1− Φ
 t− κ∑Ii=1 qik√
κ (1− κ)∑Ii=1 q2ik
 (5)
where Φ (·) is the standard Normal cumulative distribution.
4 Evaluation of random cross-screening
4.1 Random cross-screening performs poorly for Γ = 1 and K = 1
Cross-screening can perform poorly. Consider the simplest case, namely one outcome,
K = 1, no bias from unmeasured covariates, Γ = 1, where Yi1, i = 1, . . . , I, are in-
dependent observations from a Normal distribution with expectation τ and variance 1,
Yi1 ∼iid N (τ, 1), testing H1 : τ = 0 against the alternative that τ > 0. In this case, the
uniformly most powerful test is based on the mean, I−1
∑I
i=1 Yi1, the Bonferroni method
uses this best test with no correction because K = 1, and cross-screening must be inferior.
It is a mistake to use cross-screening in a randomized experiment with a small number of
null hypotheses.
More generally, we expect random cross-screening to perform poorly in comparison
with the Bonferroni-Holm method when there are few hypotheses, K ≤ 10, and the ran-
domization test, Γ = 1, or tiny biases, Γ = 1.1, are of primary interest.
The situation can be very different when K is large, perhaps K ≥ 100, and interest
is confined to findings that resist a nontrivial bias, say Γ ≥ 1.25. A bias of Γ = 1.25
corresponds with an unobserved covariate u that doubles the odds of treatment, Zi1−Zi2 =
1, and doubles the odds of a positive difference in outcomes, Yik > 0; see Rosenbaum and
Silber (2009b). Reducing K is of substantial value only if K is fairly large.
4.2 Random cross-screening and design sensitivity
If there were a treatment effect and no bias from unmeasured covariates in an observational
study, then the investigator would not be able to recognize this from the observed data,
and the best she could hope to say in this favorable situation is that the conclusions are
insensitive to moderate biases as measured by Γ. In typical situations, as the number of
pairs increases, I →∞, in this favorable situation, the degree of sensitivity to bias tends to
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a limit, called the design sensitivity, Γ˜, such that the conclusions are eventually insensitive
to all biases with Γ < Γ˜ and sensitive to some biases with Γ > Γ˜; see Rosenbaum (2004;
2010, Part III). More precisely, the upper bound on the P -value tends to 1 as I →∞ for
Γ > Γ˜, and it tends to 0 for Γ < Γ˜. In that sense, the design sensitivity Γ˜ is the limiting
sensitivity to bias as I → ∞ in a favorable situation. Moreover, the rate at which the
P -value tends to 0 as I →∞ for Γ < Γ˜ is the Bahadur efficiency of the sensitivity analysis,
and it is useful in characterizing the performance of alternative methods when Γ < Γ˜; see
Rosenbaum (2015). The Bahadur efficiency drops to zero as Γ increases to Γ˜.
Generally, the design sensitivity Γ˜ and Bahadur efficiency depend upon the nature of
the favorable situation and on the chosen methods of analysis. A poor choice of test
statistic often means an exaggerated report of sensitivity to unmeasured bias, even in large
samples. Suppose, for instance, that Yi1 ∼iid N (τ, 1), and compare Wilcoxon’s signed
rank statistic and the U-statistic (8, 5, 8) that was used in cross-screening in Table 1. If
τ = 1/2, then Γ˜ = 3.2 for Wilcoxon’s statistic, but Γ˜ = 4.2 for the U-statistic (8, 5, 8),
whereas for τ = 1 the design sensitivity is Γ˜ = 11.7 for Wilcoxon’s statistic, but Γ˜ = 26.3
for the U-statistic; see Rosenbaum (2011, Table 3). At τ = 1/2, the upper bound on the
P -value is tending to 1 as I → ∞ for Γ = 3.5 > 3.2 = Γ˜ if Wilcoxon’s statistic is used,
but it is tending to zero if (8, 5, 8) is used because Γ = 3.5 < 4.2 = Γ˜. Moreover, with
τ = 1/2 and Γ = 2, the P -value bound is tending to zero at a faster rate for (8, 5, 8) than
for Wilcoxon’s statistic, with Bahadur relative efficiency > 1.25; see Rosenbaum (2015,
Table 2). A similar pattern is found for a shift of τ with logistic or t-distributed errors.
In a randomization test with Normal or logistic errors, the Pitman efficiency of (8, 5, 8)
relative to Wilcoxon’s test is 0.97, so a small loss of efficiency in a randomization test,
Γ = 1, translates into substantial gains in a sensitivity analysis, Γ > 1. Although (8, 5, 8)
is consistently slightly better than Wilcoxon’s statistic for Γ ≥ 2, other statistics beat
(8, 5, 8) for particular error distributions with no uniform winner; see Rosenbaum (2011,
2015). Adaptive choice of a test statistic can improve design sensitivity and Bahadur
efficiency; see Berk and Jones (1978) and Rosenbaum (2012, 2015).
The considerations in the previous paragraph point to one advantage of cross-screening.
In Table 1, cross-screening adaptively picked either Wilcoxon’s statistic or (8, 5, 8) based on
their performance in the complementary half sample. As I →∞ in a favorable situation,
if two statistics have different design sensitivities, cross-screening will eventually pick the
statistic with the larger design sensitivity and report greater insensitivity to unmeasured
bias than would have resulted with a fixed but mistaken choice of statistic.
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The Bonferroni procedure can also be used to adaptively select one of two test statistics,
thereby also attaining the better of two design sensitivities. However, the Bonferroni
procedure would have to pay for adaptation by testing at level α/ (4K) rather than α/ (2K).
There are less costly ways to obtain adaptive inferences; see Rosenbaum (2012).
4.3 Expected P -values and test size in sensitivity analyses with Γ slightly too large
The Bonferroni method in Table 1 made allowance for a 0.05 chance of a false rejection of a
true hypothesis in 2K = 96 one-sided tests. Cross-screening eliminated most hypotheses,
focusing on just two of them. Was it wise to do this?
The defining feature of the sensitivity analysis (4) testing Hk is that if: (i) Hk is true
and (ii) the bias in treatment assignment is at most Γ, then the chance that the P -value
bound is less than or equal to α is at most α for each 0 ≤ α ≤ 1; that is, the P -value bound
is stochastically larger than the uniform distribution. The Bonferroni method and most
if not all methods that use P -values in controlling the family-wise error rate are designed
so that they give the correct result for P -values that are uniformly distributed. However,
with Γ > 1, it is common to see many P -value bounds that look strictly larger than the
uniform distribution.
For example, in the calculations used to carry out the cross-screening in Table 1, a
total of 2× 2× 2× 46 = 368 one-sided P -values were examined, looking at 2 tails, with 2
test statistics, in 2 halves of the data, for 46 outcomes. At Γ = 1, 40/368 = 11% of these
P -values were ≤ 0.05. However, at Γ = 1.25, only 12 P -value bounds (4) were ≤ 0.05,
and these occurred for 3 hypotheses H18, H21, and H23, in both half samples, as judged
by both statistics, 12 = 2× 2× 3. Even at Γ = 1.25, small P -value bounds were rare, and
they may all reflect a genuine effect of eating fish on the level of mercury in the blood.
What happened in Table 1 is not unexpected. SupposeHk is true and the bias in treat-
ment assignment is at most Γ′, but the sensitivity analysis is performed at Γ > Γ′. In this
case, it is quite unlikely that a true null hypothesis will yield a small P -value bound. To
demonstrate this, notice that (4) implies the statistic Tk is stochastically smaller than TΓ′k
which is stochastically smaller than TΓk, so Pr (Tk ≥ t | F , Z) ≤ Pr
(
TΓ′k ≥ t
∣∣∣ F , Z) ≤
Pr
(
TΓk ≥ t
∣∣∣ F , Z). Using (5) twice at Γ and Γ′, as I →∞ we approximate the proba-
bility that TΓ′k exceeds the upper α critical value for TΓk as
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1−Φ
(κ− κ
′)
∑I
i=1 qik +Φ
−1 (1− α)
√
κ (1− κ)∑Ii=1 q2ik√
κ′ (1− κ′)∑Ii=1 q2ik
 , (6)
where κ′ = Γ′/ (1 + Γ′). In effect, (6) is an upper bound on the size of an α-level sen-
sitivity analysis conducted with the sensitivity parameter Γ set above the true bias Γ′.
Alternatively, when Hk is true, we may approximate the expected P -value bound, that is,
the expectation of Pr
(
TΓk ≥ t
∣∣∣ F , Z) when t has the distribution of TΓ′k, as expression
(3) in Sackrowitz and Samuel-Cahn (1999),
EPV = Φ
 (κ− κ′)∑Ii=1 qik√
{κ (1− κ) + κ′ (1− κ′)}∑Ii=1 q2ik
 ; (7)
see also Dempster and Schatzoff (1965). For Wilcoxon’s signed rank statistic without ties,∑I
i=1 qik = I (I + 1) /2 and
∑I
i=1 q
2
ik = I (I + 1) (2I + 1) /6. Both (6) and (7) use the large
sample approximation to the distributions of TΓ′k and TΓk, so they make no allowance for
the discreteness of permutation distributions.
Table 2 evaluates (6) and (7) for a one-sided 0.05-level Wilcoxon test for I = 100, 250
and 500 pairs, for several values of Γ′ ≤ Γ. Of course, when Γ′ = Γ, the size-bound equals
the level-bound, 0.05, and the expected P -value is 0.5. However, when Γ′ < Γ, the size is
well below 0.05 and the expected P -value is well above 0.5, a pattern that becomes more
noticeable as I increases. If Γ is a little too large, small P -values for true hypotheses are
improbable.
Table 2 is relevant because it is uncommon to see many outcomes that are equally
sensitive to unmeasured biases; see, for instance, Table 1. Our tests must allow for this
uncommon situation as a logical possibility, but the Bonferroni method and cross-screening
do this in two very different ways, though both methods strongly control the family-wise
error rate. The Bonferroni method pays a price for every P -value bound that is computed.
Cross-screening with Γ ≥ 1.25 does not, in typical situations, pursue or spend resources on
P -value bounds that are very large.
4.4 Trade-off of sample size I and number of hypotheses K when Γ = 1
Is it ever worth half the sample to test one hypothesis rather than K hypotheses? Table 3
is several steps removed from cross-screening, but it provides one simple view of the trade-
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off of sample size I and the number of hypotheses under test K when Γ = 1. Consider
again the case in which Yi1 ∼iid N (τ, 1) and Yik ∼iid N (0, 1) for k = 2, . . . ,K, so H1 is
false and the other Hk are true. Table 3 is simply a sample size calculation for the t-test
for hypothesis H1 in the presence of K − 1 other true null hypotheses.
Table 3 shows the number of pairs, I, required for 80% power in a single two-sided
0.05-level t-test for I pair differences Yi1 that are Yi1 ∼iid N (τ, 1) when a Bonferroni
correction is made for testing a total of K hypotheses. For instance, with τ = 0.1 and
K = 1 hypothesis one needs I = 787 pairs for 80% power, but with K = 50 hypotheses the
Bonferroni correction raises that to 1,713 pairs for 80% power. In Table 3, sample sizes
that are more than twice the sample size for K = 1 are in bold.
In Table 3, for K = 50, 100, 250 and 500 hypotheses, it would be worth discarding
a random half of the data if that half correctly identified the one false null hypothesis,
thereby eliminated the need to correct for multiple testing in the remaining half of the
data. For K = 10 hypotheses, this is not true, and use of the Bonferroni correction with
the full sample yields 80% power with fewer pairs.
Table 3 is a simple, informal guide, but it is an oversimplification in many ways. First,
if several hypotheses were false, not just one, use of the Bonferroni adjustment might reject
several hypotheses. Second, cross-screening performs tests in both half-samples, but Table
3 simply discards one half-sample. Third, the conventional t-test has size equal to its level,
so the issues in §4.3 and Table 2 that arise with Γ > 1 are not reflected in Table 3.
4.5 Stylized asymptotics
One attraction of cross-screening is that it is highly flexible. For instance, one half-sample
can adaptively suggest the direction and the test statistic to be used in the other half,
and this might be done in a variety of ways. In this section, we greatly restrict, and
somewhat distort, the use of cross-screening in the hope of gleaning some analytical insight
into its behavior relative to a test that does not split the sample in half. In particular,
we do not allow cross-screening to adaptively select a test statistic, a major source of its
power. Additionally, we assume that only the first outcome is affected by the treatment
and cross-screening selects K1 = K2 = 1 hypothesis to test in each half-sample.
Suppose the sample size, I, is even and the pairs are split at random in two halves of
size I/2. Let T˙ and T¨ be the same test statistic computed for the first outcome from the
two halves of the data, where we reject H1 if the test statistic is large. Because there is
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nothing adaptive here — the choice of test statistic and the direction of the test are fixed in
advance — the statistics T˙ and T¨ are independent and have the same distribution, whether
under the null hypothesis or the alternative. Suppose that the test statistic we would use
if we did not split the sample was T˙ + T¨ . Suppose, finally, that T˙ and T¨ would each be
N (θ0, υ0) under the null hypothesis and would each be N (θ, υ) under the alternative. It
is convenient to think of T˙ and T¨ as scaled so that, as I →∞, the expectations, θ0 and θ,
are constant, while the variances, υ0 and υ, are O (2/I).
The situation just described would hold exactly with υ = υ0 for the mean of I/2 iid
Normally distributed pair differences, and it would hold asymptotically for Wilcoxon’s
signed rank test and for many other tests for paired data. The signed rank statistic for
the whole sample is not quite the same as the sum of the statistics for the two half samples,
but as I → ∞ this distinction would become unimportant. Additionally, υ 6= υ0 for the
signed rank statistic.
The combined test, T˙ + T¨ is corrected for multiple testing of K hypotheses in 2 tails, so
let ̺b = 2K. The combined test rejects the null if
(
T˙ + T¨ − 2θ0
)
/
√
2υ0 ≥ −Φ−1 (α/̺b),
with power
Pr
{
T˙ + T¨ − 2θ√
2υ
≥ 2 (θ0 − θ)− Φ
−1 (α/̺b)
√
2υ0√
2υ
}
= 1−Φ
{√
2 (θ0 − θ)− Φ−1 (α/̺b)√υ0√
υ
}
.
(8)
Now, consider cross-screening. Suppose that the first half-sample recommends testing
hypothesis k = 1 in the second half if
(
T˙ − θ0
)
/
√
υ0 ≥ −Φ−1 (α), and the second half
rejects the hypothesis if
(
T¨ − θ0
)
/
√
υ0 ≥ −Φ−1 (α/̺s) where ̺s = 2 is the cross-screening
correction testing for testing one hypothesis in two half samples. In parallel, the sec-
ond half recommends testing if
(
T¨ − θ0
)
/
√
υ0 ≥ −Φ−1 (α) and the first half rejects if(
T˙ − θ0
)
/
√
υ0 ≥ −Φ−1 (α/̺s). So cross-screening rejects hypothesis k = 1 if
max
(
T˙ − θ√
υ
,
T¨ − θ√
υ
)
≥ θ0 − θ − Φ
−1 (α/̺s)
√
υ0√
υ
= λ1, say, (9)
and
min
(
T˙ − θ√
υ
,
T¨ − θ√
υ
)
≥ θ0 − θ − Φ
−1 (α)
√
υ0√
υ
= λ2, say. (10)
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Actually, (9) and (10) embody the following small distortion. In principal, it is logically
possible, but not probable, that several of the K hypotheses satisfy (9) and (10). This
would complicate the situation; however, it is improbable because only H1 is false. For
(9) and (10) to hold for a second hypothesis, we would need to reject the same true null
hypothesis twice, once in each half-sample.
It is important to notice that
√
2 (θ0 − θ) appears on the right of (8), where θ0 − θ
appears in (9) and (10). Therefore, if I → ∞ with ̺b and ̺s fixed — that is, effectively
withK fixed — the cross-screening method has little hope of competing with the Bonferroni
method. There is, however, a serious competition if I is fixed as K increases, perhaps
with ̺s = 2 fixed and ̺b = 2K increasing.
With ̺s = 2, we many calculate the probability of the joint event (9) and (10) as
2
∫
∞
λ1
∫ y
λ2
φ (x) φ (y) dx dy (11)
where φ (·) is the standard Normal density.
In Table 4, we compare the large-sample power of a nonadaptive cross-screening test of a
one-sided hypothesis with a Bonferroni adjusted test of K two-sided hypotheses, where the
last K − 1 null hypotheses are true. The family-wise error rate is controlled at α = 0.05,
so cross-screening tests in two half samples at level α/2 = 0.025, while the Bonferroni
procedure does 2K one-sided tests at level α/ (2K). Here, cross-screening is not permitted
to use a major source of its power, namely adaptive testing. Table 4 assumes υ = υ0, as for
the Normal-mean situation above, and characterizes power in terms of the noncentrality
parameter ncp = (θ − θ0) /
√
υ.
In Table 4, we see that cross-screening is a terrible way to select one tail of a two
tailed test if there is only K = 1 hypothesis, that cross-screening is inferior for K = 10
hypotheses, but that it has higher power than the Bonferroni procedure forK = 100, 250 or
500 hypotheses. Our sense is that Table 4 offers correct qualitative advice: cross-screening
is useful when searching for a few large needles in a very big haystack, and is useless in
searching for a few hay-like needles in a small haystack. The simulation in §5 will provide
further numerical results about power free of the small distortion noted above.
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4.6 Splitting with a small planning sample
An alternative to cross-screening is single screening, as discussed in various contexts by
Cox (1975), Heller et al. (2009) and Zhang et al. (2011). In single screening, the sample
is split at random into two parts, a small planning sample and a large analysis sample.
The study is planned using the planning sample, which is then discarded. For example,
one might use the planning sample to order the hypotheses Hk, determine the side of their
one-sided alternatives, and to select test statistics. Then, with the fixed order, sides and
test statistics, the analysis sample might test the hypotheses in order. Importantly, split
screening discards the planning sample while cross-screening uses it in testing, but split
screening plans using a small planning sample while cross-screening uses a half sample.
It only takes a little thought to realize that single screening is better than cross-screening
as the sample size grows, I →∞, with the number of hypotheses K remaining fixed. See
the cited papers for related formal calculations. The reason is that the planning sample
only needs to be large enough to ensure that sensible plans are made, so that as I →∞ the
fraction of the sample needed for planning can diminish and the loss of power from using a
planning sample can diminish as well. In an application with I = 132, 786 matched pairs,
Zhang et al. (2011) used a 10% planning sample, where the 10% reduction in sample size
more than paid for itself by improving the plan for analysis of the remaining 90% of the
sample; moreover, I/10 ≈ 13, 800 pairs was an adequate sample for planning purposes. It
is doubtful that results for I → ∞ with K fixed are relevant to a situation like §1.3 with
I = 234 pairs and K = 46 hypotheses. Ten percent of I = 234 pairs is only 23 pairs,
and that may be too small a planning sample to make correct decisions about K = 46
hypotheses.
The simulation in §5 compares cross-screening to split screening with a 20% planning
sample.
5 Simulation of a sensitivity analysis testing many null hypotheses
Table 5 reports simulated power of a level-0.05 sensitivity analysis conducted with Γ = 2
with K = 100 or K = 500 hypotheses and I = 100, or 250 or 500 matched pairs. Among
the K hypotheses, one or two are false. These are situations in which cross-screening is
expected to perform well: the number of hypotheses is large compared with the sample
size, most null hypotheses are true, and a sensitivity analysis is performed with Γ > 1. As
noted previously, cross-screening should not be used to test a small number of hypotheses,
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K.
There are K independent Normal outcomes with variance 1. Outcomes k = 1 and
k = 2 have expectations τ1 and τ2, while τk = 0 for outcomes k = 3, . . . ,K. That is,
hypothesis H1 is always false with τ1 6= 0, H2 is false whenever τ2 6= 0, and Hk is true
for k = 3, . . . ,K. A value of K, I and (τ1, τ2) defines one sampling situation. In 10,000
replicates of each sampling situation, Table 5 reports the proportion of rejections of H1,
of H2 and of both H1 and H2. In each sampling situation, the highest power for each
hypothesis, H1, H2, H12, is in bold.
There are three tests. The first is the familiar Wilcoxon signed rank test. The second
test is another signed rank statistic, namely the U-statistic (8, 5, 8) from Rosenbaum (2011).
For many error distributions, the U-statistic (8, 5, 8) has a larger design sensitivity than
Wilcoxon’s statistic. Both the Wilcoxon statistic and the U-statistic (8, 5, 8) are used as
fixed tests. The third test makes an adaptive choice between three U-statistics, namely
(8, 5, 8), (8, 6, 7), and (8, 7, 8). Of these three, the U-statistic (8, 7, 8) has the highest
design sensitivity for short-tailed distributions like the Normal distribution, (8, 6, 7) has
the highest design sensitivity for long-tailed distributions like the t-distribution with 3
degrees of freedom, and (8, 5, 8) is a compromise; see Rosenbaum (2011, Table 3).
Three methods are used to strongly control the family-wise error rate in two-sided
tests. The Bonferroni method splits 0.05 among various hypotheses tests. For instance,
using Wilcoxon’s test, the Bonferroni method splits 0.05 equally among K tests each with
two tails, so a rejection occurs if the one-sided P -value bound at Γ = 2 is ≤ 0.05/ (2K).
The same approach is used with the U-statistic (8, 5, 8). For adaptive inference, the
Bonferroni method uses all three tests, but rejects if the smallest P -value bound (5) is
≤ 0.05/ (3× 2×K). The Bonferroni method attains the largest design sensitivity of
the three component tests; however, there are better approaches to adaptive inference
(Rosenbaum 2012).
Cross-screening splits the pairs in half at random, plans the analysis in the first half,
tests in the second half, then plans in the second half and tests in the first half, with a
two-fold Bonferroni correction for having done both analyses. Cross-screening does one-
tailed tests, not two-tailed tests, having selected one tail based on the planning sample.
For adaptive inference, cross-screening picks one of the U-statistics (8, 5, 8), (8, 6, 7), and
(8, 7, 8) based on the planning sample. Cross-screening orders the K hypotheses based on
the planning sample, tests the hypotheses in the analysis sample in the given order, and
stops testing with the first acceptance. It is well known that testing in order strongly
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controls the family-wise error rate; see, for instance, Koch and Gansky (1996), Hsu and
Berger (1999), Hommel and Kropf (2005), and Rosenbaum (2008). The hypotheses were
ordered by determining their sensitivity to bias in the planning sample, measured by Γ at
level α = 0.05, placing the least sensitive hypotheses first.
Single screening split the pairs at random into a 20% planning sample and an 80%
analysis sample. It discards the 20% planning sample and does one analysis based on
the 80% analysis sample, without a correction for having done two analyses. In contrast
to cross-screening, split screening: (i) omits the correction for having done two analyses,
(ii) uses a larger 80% sample in its one analysis, rather than two 50% samples, (iii) but
discards 20% of the data. Aside from these differences, the procedures for split screening
are the same as for cross-screening. Specifically, in split-screening, the planning sample
determines the tail of a one-tailed test, the order for testing-in-order, and in adaptive
inference it chooses the test statistic.
In Table 5, the highest power in most sampling situations is from cross-screening with
an adaptive choice of test statistic. Wilcoxon’s test has inferior power at Γ = 2, consistent
with results in Rosenbaum (2011); however, cross-screening often has higher power than
the Bonferroni method when the Wilcoxon test is used. The case of (τ1, τ2) = (0.6, 0.4)
for I = 500 and K = 100 is especially interesting. Using adaptive methods, both the
Bonferroni method and cross-screening reject H1 with power near 1, but cross-screening
has much higher power for H2. A similar pattern is seen for (τ1, τ2) = (0.6, 0.4) for I = 250
and K = 100 and for I = 500 and K = 500.
We repeated the simulation in Table 5 but with samples from a t-distribution on 4
degrees of freedom rather than from a Normal distribution. The comparison of Bonferroni,
cross-screening and single screening was similar to Table 5, with cross-screening having
superior power. Unlike Table 5, adaptive cross-screening was slightly to cross-screening
with a fixed choice of the U-statistic (8, 5, 8), but this is probably because (8, 5, 8) is an
excellent choice for the t-distribution with 4 degrees of freedom; see Rosenbaum (2011,
Table 4).
The simulation in Table 5 used screening to order hypotheses which were then tested in
a fixed order, terminating with the first acceptance. We also simulated several alternative
methods. Wiens (2003), Hommel and Kropf (2005) and Burman et al. (2009) proposed
fixed sequence testing procedures that test-in-order at a level below α so that they can
continue testing beyond the first acceptance. Wiens (2003) and Hommel and Kropf (2005)
transfer forward unspent α to test later hypotheses in the sequence, whereas Burman et
24
al. (2009) also cycle back to retest early hypotheses with larger α when later hypotheses
are rejected. We tried a so-called fall-back procedure, testing the first hypothesis in order
at level α/2, and the second hypothesis at level α if the first hypothesis was rejected or at
level α/2 if the first hypothesis was not rejected. We also tried recycling, meaning that if
the first hypothesis was not rejected at level α/2, but the second hypothesis was rejected
at level α/2, then the first hypothesis was retested at level α. In the situations in Table 5,
there are at most two false null hypotheses, so recycling is logically better than fall-back,
but this need not be true when three null hypotheses are false. Fixed sequence testing, as
reported in Table 5, fall-back and recycling were close competitors for each of the situations
in Table 5, and there was no consistent winner for all situations. As logic would suggest,
fixed sequence testing had a slight advantage when only H1 was false because τ2 = 0. After
all, fixed sequence testing bets all of α on the first hypothesis in the sequence. Similarly,
fall-back and recycling had a slight advantage when (τ1, τ2) = (0.5, 0.5).
Although we evaluated ordered testing procedures, one need not use any form of ordered
testing to use cross-screening. Instead, one could use the first sample to select K1 ≪ K
hypotheses to test in the second sample, and use the second to select K2 ≪ K hypotheses
to test in the second sample, and then correct for multiple testing using Holm’s (1979)
procedure. As always with cross-screening, a two-fold Bonferroni correction is needed to
analyze both half samples.
6 Nonrandom cross-screening
In some circumstances, it would be helpful to show that a treatment has the same effect in
each of two subpopulations. Nonrandom cross-screening uses an observed binary covariate
rather than random numbers to split the sample. Nonrandom and random cross-screening
each have advantages and disadvantages.
Suppose that a treatment has a large effect in one subpopulation and no effect in the
complementary subpopulation. In this case, nonrandom cross-screening will be unhelpful,
because each subpopulation will provide highly misleading advice about how to analyze
the complementary subpopulation.
Different people often receive the same treatment for different reasons. One person eats
fish because she lives on the coast of Maine and inexpensive fresh fish is abundant, while
another person eats fish in Arizona believing it to confer health benefits. When treatments
are not randomly assigned, the evidence that the treatment is the cause of its ostensible
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effects is strengthened by showing that people who receive the treatment for different
reasons experience similar effects; see Rosenbaum (2001; 2015b, §1.6) With issues of this
sort in mind, Lund and Bonaa (1993) examined the possible effects of high fish consumption
by comparing the wives of fisherman to controls of similar socioeconomic status. Although
the publicly available NHANES data does not classify people by geography or employment,
some other data set might permit people who consume high levels of fish to be divided based
on whether they eat fish believing it to be health promoting or because of its availability at
low cost. In this case, the matched pairs might be divided not at random but to distinguish
two reasons people eat fish. The study might be more convincing if it demonstrated the
same or similar ostensible effects in both types of pairs.
There is one key technical point about nonrandom cross-screening. If we view a study
as testing Fisher’s null hypothesis that asserts the treatment has no effect on anyone, then
cross-screening may be used as above to test this hypothesis while strongly controlling
the family-wise error rate. However, if both splits lead to rejection, then this achieves
Bogomolov-Heller replicability, thereby rejecting the null hypothesis of no effect for each
subpopulation. With random cross-screening, Bogomolov-Heller replicability does not
have a clear interpretation, but with nonrandom cross-screening it constitutes a distinct
strengthening of the study’s conclusions.
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Figure 1: Balance of four covariates in I = 234 matched pairs of two people, one with a
high consump- tion of fish, the other with a low consumption of fish in the past month.
29
LBXSAL
LBXSBU
LBXSCA
LBXSCH
LBXSCK
LBXSCR
LBXSGB
LBXSGL
LBXSIR
LBXSPH
LBXSTB
LBXSTP
LBXSTR
LBXSUA
WTSH2YR
LBXBPB
LBXBCD
LBXTHG
LBXBSE
LBXBMN
LBXIHG
LBXBGE
LBXBGM
LBDHDD
LBXWBCSI
LBXLYPCT
LBXMOPCT
LBXNEPCT
LBXEOPCT
LBXBAPCT
LBDLYMNO
LBDMONO
LBDNENO
LBDEONO
LBDBANO
LBXRBCSI
LBXHGB
LBXHCT
LBXMCVSI
LBXMCHSI
LBXMC
LBXRDW
LBXPLTSI
LBXMPSI
LBXGH
−5 0 5
log2(high) − log2(low)
Figure 2: I = 234 High-minus-Low matched pair differences, Yik, of log2(Rijk) for outcomes
k = 1, . . . , 46. A difference of 1 on the log2-scale is 1 doubling. Note the boxplots for
LBXBGM and LBXTHG describing mercury in the blood.
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Table 1: Bonferroni correction (B) versus cross-screening (CS) with K = 46 outcomes
and Γ = 1, 1.25, 9, and 11. A blank indicates that no test was performed.
Sensitivity Parameter Γ = 1 Γ = 1.25 Γ = 9 Γ = 11
Outcome k B CS B CS B CS B CS
LBXSAL Albumin 1 1.000 1.000 1.000 1.000
LBXSBU Blood urea nitrogen 2 1.000 1.000 1.000 1.000
LBXSCA Total calcium 3 1.000 1.000 1.000 1.000
LBXSCH Cholesterol 4 1.000 1.000 1.000 1.000
LBXSCK Creatine phospho. 5 1.000 1.000 1.000 1.000
LBXSCR Creatinine 6 1.000 1.000 1.000 1.000
LBXSGB Globulin 7 1.000 1.000 1.000 1.000
LBXSGL Glucose 8 1.000 1.000 1.000 1.000
LBXSIR Iron 9 1.000 1.000 1.000 1.000
LBXSPH Phosphorus 10 1.000 1.000 1.000 1.000
LBXSTB Total bilirubin 11 1.000 1.000 1.000 1.000
LBXSTP Total protein 12 1.000 1.000 1.000 1.000
LBXSTR Triglycerides 13 1.000 1.000 1.000 1.000
LBXSUA Uric acid 14 1.000 1.000 1.000 1.000
WTSH2YR Blood metals 15 0.024 1.000 1.000 1.000
LBXBPB Blood lead 16 1.000 1.000 1.000 1.000
LBXBCD Blood cadmium 17 1.000 1.000 1.000 1.000
LBXTHG Blood mercury 18 0.000 0.000 0.000 0.000 0.095 0.015 0.505 0.035
LBXBSE Blood selenium 19 0.380 1.000 1.000 1.000
LBXBMN Blood manganese 20 1.000 1.000 1.000 1.000
LBXIHG Mercury, inorganic 21 0.000 0.000 1.000 1.000
LBXBGE Mercury, ethyl 22 1.000 1.000 1.000 1.000
LBXBGM Mercury, methyl 23 0.000 0.000 0.000 0.000 0.075 0.014 0.405 0.031
LBDHDD HDL-Cholesterol 24 1.000 1.000 1.000 1.000
LBXWBCSI White blood cell cnt. 25 1.000 1.000 1.000 1.000
LBXLYPCT Lymphocyte % 26 1.000 1.000 1.000 1.000
LBXMOPCT Monocyte % 27 1.000 1.000 1.000 1.000
LBXNEPCT Seg. neutrophils % 28 1.000 1.000 1.000 1.000
LBXEOPCT Eosinophils % 29 1.000 1.000 1.000 1.000
LBXBAPCT Basophils % 30 1.000 1.000 1.000 1.000
LBDLYMNO Lymphocyte # 31 1.000 1.000 1.000 1.000
LBDMONO Monocyte # 32 1.000 1.000 1.000 1.000
LBDNENO Seg. neutrophils # 33 1.000 1.000 1.000 1.000
LBDEONO Eosinophils # 34 1.000 1.000 1.000 1.000
LBDBANO Basophils # 35 1.000 1.000 1.000 1.000
LBXRBCSI Red blood cell cnt. 36 1.000 1.000 1.000 1.000
LBXHGB Hemoglobin 37 1.000 1.000 1.000 1.000
LBXHCT Hematocrit 38 1.000 1.000 1.000 1.000
LBXMCVSI Mean cell volume 39 1.000 1.000 1.000 1.000
LBXMCHSI Mean cell hemoglobin 40 1.000 1.000 1.000 1.000
LBXMC MCHC 41 1.000 1.000 1.000 1.000
LBXRDW Red cell dist. 42 0.520 1.000 1.000 1.000
LBXPLTSI Platelet count 43 1.000 1.000 1.000 1.000
LBXMPSI Mean platelet vol. 44 1.000 1.000 1.000 1.000
LBXGH Glycohemoglobin 45 1.000 1.000 1.000 1.000
BPXSY Systolic BP 46 0.523 1.000 1.000 1.000
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Table 2: When Hk is true and the bias in treatment assignment is at most Γ
′, the table
gives the upper bound on the size of an α = 0.05 level Wilcoxon test and the upper bound
on the expected P -value (EPV) if the sensitivity analysis is performed with sensitivity
parameter Γ ≥ Γ′
.
Bound on Size Bound on EPV
Γ′ Γ I = 100 I = 250 I = 500 I = 100 I = 250 I = 500
1.00 1.00 0.05000 0.05000 0.05000 0.50 0.50 0.50
1.00 1.10 0.01976 0.01077 0.00511 0.62 0.68 0.74
1.00 1.25 0.00445 0.00074 0.00007 0.75 0.86 0.94
1.10 1.25 0.01392 0.00586 0.00197 0.65 0.73 0.81
1.25 1.25 0.05000 0.05000 0.05000 0.50 0.50 0.50
1.25 1.50 0.00750 0.00194 0.00033 0.71 0.81 0.89
1.50 2.00 0.00204 0.00017 0.00001 0.80 0.91 0.97
Table 3: Number of pairs required for power 0.8 with family-wise error rate 0.05 using the
two-sided t-test with a Bonferroni correction for performing K hypothesis tests. When the
value in column K is more than twice the value in column K = 1, the sample size is in
bold.
τ K=1 K=10 K=50 K=100 K=250 K=500
.1 787 1335 1713 1874 2087 2247
.3 89 152 195 214 238 256
.5 33 57 74 81 90 97
Table 4: Comparison of the large-sample power of 0.05-level testing of one, one-sided
hypothesis by cross-screening (CS) versus testing K = 1, 10, 50, 100, 250 and 500 two-
sided hypotheses using the Bonferroni method. Cases in which the Bonferroni method has
lower power than CS are in bold.
Bonferroni with K hypotheses
ncp CS 1 10 50 100 250 500
1 0.0591 0.2926 0.0818 0.0303 0.0194 0.0106 0.0066
2 0.3929 0.8074 0.5085 0.3220 0.2571 0.1866 0.1441
3 0.8285 0.9888 0.9244 0.8295 0.7769 0.6997 0.6376
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Table 5: Simulated power at Γ = 2 with Normal errors for K independent outcomes in I
matched pairs. For outcome k = 1, hypotheses H1 is false with pair differences symmetric
about τ1 6= 0. For outcome k = 2, hypotheses H2 is false whenever τ2 6= 0. Null hypotheses
k = 3, . . . ,K are true, with pair differences that are symmetric about zero. Tabulated
values are the proportion of rejections at the 0.05-level in 10,000 replicates. The column
labeled H12 is the proportion of times bothH1 andH2 were both rejected. In each sampling
situation, the highest power for each hypothesis is in bold.
Bonferroni Cross screening Single screening
K I (τ1, τ2) Statistic H1 H2 H12 H1 H2 H12 H1 H2 H12
100 100 (0.5,0.0) Wilcoxon 1.4 23.0 11.2
(8,5,8) 2.9 28.4 13.2
Adaptive 1.3 27.4 11.2
(0.5,0.5) Wilcoxon 1.2 1.5 0.0 15.2 16.0 3.6 10.3 10.8 1.8
(8,5,8) 3.0 2.8 0.1 19.1 19.6 5.4 11.8 11.5 2.0
Adaptive 1.2 1.0 0.0 21.3 21.6 6.7 10.9 11.4 1.8
(0.6,0.4) Wilcoxon 9.6 0.2 0.0 47.8 3.7 2.6 28.8 2.5 1.1
(8,5,8) 14.5 0.2 0.0 52.1 5.0 3.5 28.5 3.0 1.1
Adaptive 7.8 0.1 0.0 50.9 6.1 4.2 25.5 3.7 1.3
250 (0.5,0.0) Wilcoxon 18.7 72.7 57.8
(8,5,8) 31.1 82.1 60.9
Adaptive 35.0 88.3 60.0
(0.5,0.5) Wilcoxon 19.4 17.9 3.5 53.7 53.1 39.8 54.0 53.3 34.0
(8,5,8) 30.5 30.5 9.5 66.7 67.1 56.3 59.0 59.2 39.1
Adaptive 36.3 35.1 12.6 79.3 79.2 70.7 59.5 59.3 38.9
(0.6,0.4) Wilcoxon 71.4 0.9 0.6 90.4 20.7 20.6 78.5 15.3 13.7
(8,5,8) 83.0 2.8 2.3 93.6 31.8 31.7 79.9 21.4 19.3
Adaptive 84.2 4.2 3.5 95.5 44.4 44.2 78.4 25.5 22.2
500 (0.5,0.0) Wilcoxon 66.7 96.3 95.3
(8,5,8) 82.8 98.8 95.9
Adaptive 92.7 99.8 95.0
(0.5,0.5) Wilcoxon 66.8 66.5 44.6 91.3 91.1 88.2 93.8 93.9 90.1
(8,5,8) 82.6 82.7 68.6 96.5 96.8 95.7 95.7 95.9 92.6
Adaptive 92.7 92.7 85.9 99.4 99.5 99.2 95.4 95.1 91.2
(0.6,0.4) Wilcoxon 99.3 4.8 4.8 99.4 45.9 45.9 95.5 46.1 46.0
(8,5,8) 99.9 13.1 13.1 99.8 64.9 64.9 97.0 60.7 60.5
Adaptive 100.0 30.8 30.8 100.0 86.5 86.5 98.4 70.8 70.6
500 500 (0.5,0.0) Wilcoxon 47.5 96.3 90.5
(8,5,8) 68.4 99.0 90.7
Adaptive 83.0 99.8 87.8
(0.5,0.5) Wilcoxon 48.5 48.8 23.7 91.1 91.2 88.3 89.4 89.5 82.0
(8,5,8) 68.7 69.0 47.7 96.8 96.7 95.7 90.3 90.6 82.9
Adaptive 83.7 83.9 70.3 99.5 99.5 99.3 88.2 88.7 79.1
(0.6,0.4) Wilcoxon 97.8 1.8 1.7 99.5 45.9 45.9 94.7 39.0 38.6
(8,5,8) 99.3 5.8 5.7 99.7 63.9 63.9 96.2 49.5 49.0
Adaptive 99.9 16.2 16.2 100.0 85.7 85.7 96.9 57.2 56.2
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